These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7634617)

  • 21. Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients.
    Paradiso A; Tommasi S; Barletta A; Leone B; Lacava J; Vellejo C; Labriola A; Marzullo F; Altieri R; Schittulli F; De Lena M
    Anticancer Res; 1999; 19(5C):4523-8. PubMed ID: 10650804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis.
    Henderson MA; Danks JA; Slavin JL; Byrnes GB; Choong PF; Spillane JB; Hopper JL; Martin TJ
    Cancer Res; 2006 Feb; 66(4):2250-6. PubMed ID: 16489028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone-related peptide: expression in prostate cancer bone metastases.
    Bryden AA; Islam S; Freemont AJ; Shanks JH; George NJ; Clarke NW
    Prostate Cancer Prostatic Dis; 2002; 5(1):59-62. PubMed ID: 15195132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
    Siclari VA; Guise TA; Chirgwin JM
    Cancer Metastasis Rev; 2006 Dec; 25(4):621-33. PubMed ID: 17165131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion.
    Pelte MF; Schwaller J; Cerrato C; Meier CA
    Breast J; 2004; 10(4):350-4. PubMed ID: 15239795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway.
    Shen X; Qian L; Falzon M
    Exp Cell Res; 2004 Apr; 294(2):420-33. PubMed ID: 15023531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
    Takayama S; Ishii S; Ikeda T; Masamura S; Doi M; Kitajima M
    Anticancer Res; 2005; 25(1A):79-83. PubMed ID: 15816522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone related protein in breast cancers of widely varying prognosis.
    Kissin MW; Henderson MA; Danks JA; Hayman JA; Bennett RC; Martin TJ
    Eur J Surg Oncol; 1993 Apr; 19(2):134-42. PubMed ID: 8491317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of breast cancer bone metastasis.
    Zhang Y; Ma B; Fan Q
    Cancer Lett; 2010 Jun; 292(1):1-7. PubMed ID: 20006425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer bone metastasis and current small therapeutics.
    Cicek M; Oursler MJ
    Cancer Metastasis Rev; 2006 Dec; 25(4):635-44. PubMed ID: 17160709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-bone cellular interactions in skeletal metastases.
    Chirgwin JM; Mohammad KS; Guise TA
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):308-18. PubMed ID: 15615499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
    Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
    Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival.
    Shabo I; Olsson H; Stål O; Svanvik J
    Clin Breast Cancer; 2013 Oct; 13(5):371-7. PubMed ID: 23810293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases.
    Henderson M; Danks J; Moseley J; Slavin J; Harris T; McKinlay M; Hopper J; Martin T
    J Natl Cancer Inst; 2001 Feb; 93(3):234-7. PubMed ID: 11158193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.